New Zealand markets closed

PODD Jun 2024 220.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.05000.0000 (0.00%)
As of 11:50AM EDT. Market open.
Full screen
Previous close0.0500
Open0.0500
Bid0.0000
Ask0.0000
Strike220.00
Expiry date2024-06-21
Day's range0.0100 - 0.0500
Contract rangeN/A
Volume5
Open interestN/A
  • Business Wire

    Insulet Announces Full Commercial Launch of Omnipod 5 with Expanded Sensor Integrations in the United Kingdom and the Netherlands

    ACTON, Mass., June 20, 2024--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that Omnipod 5, compatible with both Dexcom G6 and Abbott FreeStyle Libre 2 Plus continuous glucose monitor (CGM) sensors, is now fully available in the U.K. and the Netherlands for individuals aged two years and older with type 1 diabetes. Omnipod 5 is the first and only tubeless automated insulin del

  • Business Wire

    Insulet Announces Omnipod 5 Launch in France and U.S. Innovation Updates

    ACTON, Mass., June 20, 2024--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today made several exciting announcements regarding the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), including its availability in France with Dexcom G6 compatibility, as well as two updates for the U.S. market — the commencement of the Omnipod 5 with Dexcom G7 integration full commercial launch as well as

  • GuruFocus.com

    Insider Sale at Insulet Corp (PODD) by SVP & Chief Technology Officer Mark Field

    On June 14, 2024, Mark Field, Senior Vice President & Chief Technology Officer of Insulet Corp (NASDAQ:PODD), executed a sale of 1,500 shares of the company.